Processa Pharmaceuticals adjourns annual meeting due to lack of quorum; reconvened on July 18, 2025

Processa Pharmaceuticals, Inc.

Annual meeting on June 30, 2025, adjourned due to insufficient quorum; no business conducted.
Meeting reconvened on July 18, 2025, at 9:00 AM in Hanover, MD; record date unchanged (May 1, 2025).
Proxies already submitted remain valid; no action needed for shareholders who have already voted.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.